Facebook
X
LinkedIn
ForwardMultiple Sclerosis and Autoimmune Neurology Update Online Course
Course Directors: Eoin P. Flanagan, M.B., B.Ch.
Access to online streaming course is available from the date of purchase until the course expires on May 7, 2027. Credit must be claimed within that time period.
This state-of-the-art update on multiple sclerosis and autoimmune neurology is designed to provide evidence-based strategies that focus on practical multidisciplinary clinical care. We welcome a variety of specialists and primary care physicians who have a specific interest in this field.
Target Audience
The target audience includes allied health professional, nurse, nurse practitioner, physician, physician assistant, resident/fellow, physical and occupational therapists, social workers, and anyone with an interest in multiple sclerosis and autoimmune neurology.
Learning Objectives
- Analyze the range of therapeutic options for aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorders.
- Interpret strategies for selecting first and subsequent disease-modifying therapies for patients with relapsing or progressive MS.
- Summarize how to diagnose autoimmune encephalitis and the risk factors for misdiagnosis
- Differentiate the clinical, laboratory and neuroimaging characteristics of myelin oligodendrocyte glycoprotein-associated disorders.
- Recognize appropriate management of common MS symptoms.
Utilization of this Mayo Clinic online (enduring materials) course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be in this course.
Additional Information
| Attachment | Size |
|---|---|
 Additional Information | 167.06 KB |
| Multiple Sclerosis and Autoimmune Neurology Update Online Course | ||
| May 8, 2026 - May 7, 2027 | ||
| Duration | Lecture Title | Speaker(s) |
| Section I | ||
| 0:42:55 | Neuroimaging in MS | Jiwon Oh, M.D., PhD., FRCPC |
| 0:24:42 | MS Diagnosis: From Radiologically Isolated Syndrome to Relapsing MS | Orhun H. Kantarci, M.D. |
| 0:29:22 | Central Nervous System Inflammatory Demyelinating Disease in Children | Jan-Mendelt Tillema, M.D. |
| 0:31:26 | Cognitive Aspects of Multiple Sclerosis | Michael R. Basso, Ph.D., L.P. |
| Section II | ||
| 0:23:12 | Progressive MS: Pathogenesis and Treatment | B. Mark Keegan, M.D. |
| 0:14:57 | Case Vignettes: Variant of Progressive Multiple Sclerosis / MS and Mimics: Case Vignette | Naga Pradyumna (Naga) Kothapalli, M.B.B.S. Kathryne (Katy) N. Wood, M.D. |
| 0:29:56 | Aquaporin-4-IGG Positive Neuromyelitis Optica Spectrum Disorders | Dean M. Wingerchuk, M.D. |
| 0:25:40 | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | Eoin P. Flanagan, M.B., B.Ch. |
| Section III | ||
| 0:29:02 | Autoimmune Encephalitis Diagnosis and Misdiagnosis | Alfonso (Sebastian) S. Lopez Chiriboga, M.D. |
| 0:27:53 | Antibody Discovery to Effective Treatment: From Bench to Bedside | Sean J. Pittock, M.D. |
| 0:24:55 | Autoimmune Encephalitis: Cases | Gregory (Gregg) S. Day, M.D. |
| 0:29:43 | Paraneoplastic Neurologic Syndrome: A Practical Cased Based Approach to Diagnosis | Divyanshu Dubey, M.B.B.S. |
| Section IV | ||
| 0:24:26 | Neurologic Infections in Immunocompromised Patients: Cases | Michel Toledano, M.D. |
| 0:34:49 | Lower/Moderate Efficacy Treatments in Relapsing Multiple Sclerosis | Cristina Valencia Sanchez, M.D., Ph.D. |
| 0:36:54 | High Efficacy Therapies for Relapsing MS | Jonathan L. Carter, M.D. |
| Section V | ||
| 0:28:16 | Women with MS: Treatment Considerations | Burcu Zeydan, M.D. |
| 0:30:11 | Symptomatic Treatment in MS | Iris (Vanessa) V. Marin Collazo, M.D. |
| 0:30:32 | Therapeutic Approach and Outcome in Autoimmune and Paraneoplastic Disorders of CNS | Anastasia Zekeridou, M.D., Ph.D. |
| 10:11:51 Content Hours | ||
| 10.00 Credit Hours | ||
Course Directors
Eoin P. Flanagan, M.B., B.Ch.
Faculty
Alfonso (Sebastian) S. Lopez Chiriboga, M.D.
Anastasia Zekeridou, M.D., Ph.D.
B. Mark Keegan, M.D.
Burcu Zeydan, M.D.
Cristina Valencia Sanchez, M.D., Ph.D.
Dean M. Wingerchuk, M.D.
Divyanshu Dubey, M.B.B.S.
Eoin P. Flanagan, M.B., B.Ch.
Gregory (Gregg) S. Day, M.D.
Iris (Vanessa) V. Marin Collazo, M.D.
Jan-Mendelt Tillema, M.D.
Jiwon Oh, M.D., PhD., FRCPC
Jonathan L. Carter, M.D.
Kathryne (Katy) N. Wood, M.D.
Michael R. Basso, Ph.D., L.P.
Michel Toledano, M.D.
Naga Pradyumna (Naga) Kothapalli, M.B.B.S.
Orhun H. Kantarci, M.D.
Sean J. Pittock, M.D.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 10.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 10.00 AMA PRA Category 1 Credit™
- 10.00 Attendance
Price
Prospective attendees, please note that the content for this online activity has been repurposed from the live education activity 2023 Multiple Sclerosis and Autoimmune Neurology Update 2/3/2023-2/4/2023. If you attended the live activity, you have already received credit for these educational sessions.
Access to online streaming course is available from the date of purchase until the course expires on May 7, 2027. Credit must be claimed within that time period.
Commitment to Belonging and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which all individuals are valued, allowing all to achieve their fullest potential.
Every effort will be made to accommodate dietary requirements; however, some requests may not be feasible based on venue kitchen capabilities. Attendees will be contacted in advance if a dietary restriction cannot be fulfilled.
The Mayo Clinic School of Continuous Professional Development strives for fully accessible learning experiences. If you anticipate any barriers while attending this course, please reach out to the course coordinator who will be in touch with all registrants. If you need disability-related accommodations, please contact the Office of Wellness and Academic Support – Disability Access Services at MCCMS.DS@mayo.edu.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.